Wu M, Mergia A
Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, Florida 32610, USA.
J Virol. 1999 May;73(5):4498-501. doi: 10.1128/JVI.73.5.4498-4501.1999.
Foamy viruses are nonpathogenic retroviruses that offer several unique opportunities for gene transfer in various cell types from different species. We have previously demonstrated the utility of simian foamy virus type 1 (SFV-1) as a vector system by transient expression assay (M. Wu et al., J. Virol. 72:3451-3454, 1998). In this report, we describe the first stable packaging cell lines for foamy virus vectors based on SFV-1. We developed two packaging cell lines in which the helper DNA is placed under the control of either a constitutive cytomegalovirus (CMV) immediate-early gene or inducible tetracycline promoter for expression. Although the constitutive packaging expressing cell line had a higher copy number of packaging DNA, the inducible packaging cell line produced four times more vector particles. This result suggested that the structural gene products in the constitutively expressing packaging cell line were expressed at a level that is not toxic to the cells, and thus vector production was reduced. The SFV-1 vector in the presence of vesicular stomatitis virus envelope protein G (VSV-G) produced an insignificant level of transduction, indicating that foamy viruses could not be pseudotyped with VSV-G to generate high-titer vectors. The availability of stable packaging cell lines represents a step toward the use of an SFV-1 vector delivery system that will allow scaled-up production of vector stocks for gene therapy.
泡沫病毒是无致病性的逆转录病毒,为在来自不同物种的多种细胞类型中进行基因转移提供了几个独特的机会。我们之前通过瞬时表达分析证明了1型猿猴泡沫病毒(SFV-1)作为载体系统的实用性(M. Wu等人,《病毒学杂志》72:3451 - 3454,1998年)。在本报告中,我们描述了首个基于SFV-1的泡沫病毒载体稳定包装细胞系。我们开发了两种包装细胞系,其中辅助DNA分别置于组成型巨细胞病毒(CMV)立即早期基因或可诱导的四环素启动子的控制下进行表达。虽然组成型包装表达细胞系的包装DNA拷贝数更高,但可诱导包装细胞系产生的载体颗粒多四倍。这一结果表明,组成型表达包装细胞系中的结构基因产物表达水平对细胞无毒,因此载体产量降低。在水疱性口炎病毒包膜蛋白G(VSV-G)存在的情况下,SFV-1载体产生的转导水平微不足道,表明泡沫病毒不能用VSV-G进行假型化以产生高滴度载体。稳定包装细胞系的可用性代表着朝着使用SFV-1载体递送系统迈出了一步,该系统将允许扩大载体储备的生产用于基因治疗。